Lonza (O6Z) Annual Reports

Lonza Group Ltd is a corporation incorporated under the laws of Switzerland and

has been listed on the SIX Swiss Exchange (the “SIX”) since November 1999.

Lonza is a supplier to the pharmaceutical, healthcare and life sciences

industries with products and services spanning from research to final product

manufacture to meet customers’ needs. The products Lonza manufacture for the

life sciences industry can be characterised as very complex molecules which are

manufactured in a highly regulated environment and will end up in the body of

human beings or animals.

Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and

biotechnology industries. The Group has strong capabilities in large and small

molecules, peptides, amino acids and niche bioproducts which play an important

role in the development of novel medicines and healthcare products. The Group

provides cell-based research, endotoxin detection and cell therapy

manufacturing. The Group is also a provider of high value chemicals and biotech

ingredients to the nutrition, hygiene, preservation, agro and personal care

markets.

To provide optimal support to its customers, the Group is organized into three

business divisions, namely, Custom Manufacturing, Life Science Ingredients and

Bioscience, which focus on specific sets of customers and their needs.